Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2019 Nov;39(11):1562-1568.
doi: 10.1038/s41372-019-0487-6. Epub 2019 Sep 6.

Risk of development of treated retinopathy of prematurity in very low birth weight infants

Samantha Gonski  1 , Susan R Hupp  2 , C Michael Cotten  3 , Reese H Clark  4 , Matthew Laughon  5 , Kevin Watt  3   6 , Christoph P Hornik  3   6 , Karan Kumar  3 , P Brian Smith  3   6 , Rachel G Greenberg  7   8
Affiliations
Multicenter Study

Risk of development of treated retinopathy of prematurity in very low birth weight infants

Samantha Gonski et al. J Perinatol. 2019 Nov.

Abstract

Objective: Quantify the risk of treatment for retinopathy of prematurity (ROP) among infants meeting current U.S. screening guidelines.

Study design: Among infants ≤1500 g birth weight or ≤30 weeks gestation screened for ROP from 2006-2015, we developed a risk prediction model to identify infants treated for ROP. We applied our model to a separate infant cohort discharged in 2016.

Result: Seventy-five thousand eight hundred and twenty one infants met inclusion criteria; 2306 (3%) were treated for ROP. Infants with several risk factor combinations (no ventilator support or oxygen on postnatal day 28, no history of necrotizing enterocolitis, and no intraventricular hemorrhage) were at low risk of ROP. Applied to 6127 infants discharged in 2016, our model had 97.9% sensitivity, 63.3% specificity, positive predictive value of 4.0%, and negative predictive value of 99.9%.

Conclusion: Large numbers of infants at low risk of developing ROP are required to undergo screening. Refining current ROP guidelines may reduce unnecessary examinations.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest disclosures: The authors report no relevant conflicts of interest.

Figures

Figure 1.
Figure 1.
Study flow diagram ROP, retinopathy of prematurity
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Bashinsky AL. Retinopathy of prematurity. N C Med J. 2017;78:124–8. - PubMed
    1. Wang H. Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy. Eye Brain. 2016;8:81–90. - PMC - PubMed
    1. National Eye Institute. Facts about Retinopathy of Prematurity (ROP). National Institutes of Health National Eye Institute web site. https://nei.nih.gov/health/rop. Accessed September 24, 2018.
    1. Steinkuller PG, Du L, Gilbert C, Foster A, Collins ML, Coats DK. Childhood blindness. J AAPOS. 1999;3:26–32. - PubMed
    1. Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev. 2008;84:77–82. - PubMed

Publication types